Chargui, Jamel <br/><br/>
Bromohydrin pyrophosphate-stimulated Vgamma9delta2 T cells expanded ex vivo from patients with poor-prognosis neuroblastoma lyse autologous primary tumor cells.  [electronic resource] 

 -  Journal of immunotherapy (Hagerstown, Md. : 1997)   
 - 591-8 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1537-4513 
<br/><br/><label>Standard No.: </label>10.1097/CJI.0b013e3181dda207  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antigens, Neoplasm--immunology<br/>Cancer Vaccines<br/>Cell Line, Tumor<br/>Cell Proliferation<br/>Cytokines--metabolism<br/>Cytotoxicity, Immunologic<br/>Diphosphates--immunology<br/>Disease Progression<br/>Humans<br/>Lymphocyte Activation<br/>Neoplasm Staging<br/>Neuroblastoma--immunology<br/>Prognosis<br/>Receptors, Antigen, T-Cell, gamma-delta--metabolism<br/>T-Lymphocytes--immunology